Our results also demonstrated the anti-inflammatory effect of both drugs, especially paricalcitol and the combined treatment, as the inflammatory markers (IL-6 and TNF-α) were significantly increased as a result of induction of diabetes, then improved in treated groups in the order of enalapril + paricalcitol > paricalcitol > enalapril. Here, IL6 is linked to diabetes mellitus.